Revvity, ES-012-C, ValiScreen Human Adenosine A Cell Line

Overview
Revvity's ValiScreen cell lines are provided in two vials of frozen cells, each containing ~2.5 x 106 cells. Detailed product information as well as recommended cell culture conditions and validation assay date are available each cell line.
Clonal selection Revvity's ValiScreen cell lines is carried out with receptor binding. High and low expressors are n tested and selected optimal binding and functional response according to receptor specific transduction pathway.
Revvity’s ValiScreen cell lines require accepted cell line Terms and Conditions prior to order processing. Additional agreement needed for commercial use. Please use link above to accept Terms and Conditions or to request an agreement for commercial use.
Application-cAMP Drug Discovery & Development
Brand-ValiScreen
G-Alpha Natural Receptor-G i /G o
Host Cell Line-CHO-K1
Host Species-Human
One Unit Contains-2 vial(s)
Product Group-Cell Line
Receptor-Adenosine
Second Messenger Release-cAMP GTP exchange
Shipping Conditions-Shipped in Dry Ice
Special Ordering Information-Requires accepted Terms and Conditions. Additional agreement needed for commercial use.
Target Class-GPCR
Therapeutic Area-Cardiovascular Central Nervous System Inflammation Metabolic
Unit Size-5 million
Validation-Binding cAMP GTPγS